A Study of Distal Jejunal-release Dextrose in Obese Participants

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT05385978

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Aphaia Pharma US LLC (from the registry)
Registry
  • NCT NCT05385978
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Georgia, Germany, Puerto Rico (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05385978. Randomized; quadruple masking; primary purpose treatment. Start 2022-11-01 (actual); primary completion 2024-11-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Distal Jejunal-release Dextrose in Obese Participants
Condition
Obese
Intervention (Drug)
APHD-012
Intervention (Drug)
APHD-012P
Lead sponsor
Aphaia Pharma US LLC (class: industry)

Record details

Record id
cardio:ct-nct05385978
Content hash
567558c8ebf132fe90be2c94bce3477e20a14a57aa922d90ac1aa6a496173f93